left ventricular hypertrophy and arterial intima-media thickening, suggesting that increased ET concenBackground. Plasma endothelin ( ET ) is elevated in end-stage renal disease ( ESRD), but the origin and trations in ESRD patients may be of pathophysiological significance in the process of cardiovascular consequences of this increase remain unclear. In the present study we analysed the relationships between remodelling. plasma ET levels and cardiovascular alterations in ESRD.
Subjects and methods
of the measurements was ±0.273 mm for CCAD. Measurements were done on the right CCA, two centimeters Subjects beneath the bifurcation. CCA intima-media thickness (IMT ) was measured on the far wall at the same level as the Stable, non-diabetic, ESRD patients (n=76) on haemodia-diameter measurements with computer-assisted acquisition, lysis for 105±85 months (6-312 months) were included. processing and storage. The computing equipment was linked Age-, sex-, and blood pressure (BP)-matched non-uraemic to an 80386/16 MHz processor and an imaging card providsubjects (n=57) served as the control group. On the basis of ing real-time digitizing of the video analogue signal from the clinical report and complementary paraclinical investigations echo recording (processing corresponding to 256 levels of (echocardiography, ECG, echodoppler study) patients or gray). The IMT was automatically analysed from changes in controls with acute myocardial infarction, valvular heart density on the section perpendicular to the vessel wall with disease, cerebral vascular disease, common carotid artery dedicated software ( Eurequa; TSA, Meudon, France) [24] . stenosis, and heart failure (according to American Heart The repeatability coefficient of the IMT measurement was Association criteria) were excluded. ESRD patients (n=50) ±60 mm [4] . The CCA intima-media cross-sectional area were being treated with regular recombinant human erythro-was calculated as p(CCAD/2+IMT )2-p(CCAD/2)2. A localpoietin. In all, 22 ESRD patients and 15 controls were taking ized echostructure encroaching into the vessel lumen was antihypertensive therapy, which was stopped 4 weeks prior considered to be a plaque if the CCA-IMT was >50% to the study. Seven ESRD patients had had binephrectomy thicker than neighbouring sites. A semiquantitative scale was performed 168-300 months before the study. Patients were used to assess plaque occurence: grade 1=no plaque, and dialysed with an AN69 membrane (Hospal, Meyzieu, France) grade 2=plaque present. CCAD and CCA-IMT measurewith bicarbonate dialysate. The duration of dialysis was ments were always performed in plaque-free arterial individually tailored (4-6 h thrice weekly) to control body segments. fluids and blood chemistry, and to achieve a Kt/V>1.2 (1.52±0.15). Investigations were performed in the morning
Arterial stiffness
before the mid-week haemodialysis session. Each subject provided informed written consent for the study, which was
The carotid-femoral PWV (CF-PWV ) was determined using approved by our institutional review board.
the foot-to-foot method [4, 25] . CCA and femoral artery pressure waveforms were recorded non-invasively with a
Cardiac measurements
pencil-type probe incorporating a high-fidelity Millar strain gauge transducer in the tip of the probe (SPT-301; Millar Echocardiographic studies were performed using a Hewlett-Instruments, Houston, TX, USA). Pressure waveform Packard Sonos 100 device (HP, Evry, France) equipped with recordings were carried out simultaneously at the base of the a 2.25 MHz probe allowing M-mode, two-dimensional, and neck over the CCA and the femoral artery in the groin and pulsed Doppler measurements. Measurements were per-recorded with a Gould 8188 recorder (Gould Electronique, formed blindly by two physicians according to the American Ballainvilliers, France) at a speed of 100 mm/s. The time Society of Echocardiography [22] . M-mode measurements delay (t) was measured between the feet of the pressure included left ventricular (LV ) posterior wall thickness waves recorded at these different points. The time delay was (PWT ), interventricular septal thickness (IVS), LV end-averaged over 10-15 beats. The distance travelled by the diastolic diameter (LVEDD), and LV end-systolic diameter pulse wave (D) was measured over the body surface as the (LVESD). LV mass was calculated according to the Penn distance between the two recording sites minus that from the convention [23] , and LV mean wall thickness as suprasternal notch to the carotid. PWV was calculated as (IVS+PWT )/2. Fractional shortening was calculated as PWV=D/t. Left ventricular ejection time (LVET ) and heart [(LVEDD-LVESD)/LVEDD]×100. LV outflow and aortic period were determined from CCA pressure wave records as velocities were taken from the apical position, and mitral previously described [4] . inflow velocities with the signal positioned at the tip of the mitral leaflets.
Forearm reactive hyperaemia Blood pressure (BP) and arterial measurements
Forearm blood flow (FBF in ml/100ml/min) was measured by venous occlusion plethysmography (on the forearm conBrachial BP was measured with a mercury sphygmomano-tralateral to the arteriovenous shunt in ESRD) in 40 control meter after 15 min of recumbency. Phases I and V of the subjects and 49 ESRD patients. The forearm was placed in Korotkoff sounds were taken respectively as the systolic BP adduction 10 cm above heart level. A pneumatic venous (SBP) and diastolic BP (DBP). The mean BP (MBP) was occlusion cuff was placed around the upper arm and concalculated as: MBP=DBP+(SBP-DBP/3). Five measure-nected to an automatic inflator. A mercury strain gauge was ments 2 min apart were averaged.
placed on the largest part of the arm distal to the humeral epicondyle. After calibration, venous occlusion was achieved
Common carotid artery diameter and intima-media
by cuff inflation to 50 mm Hg over 2 s for the measurement of baseline blood flow. The reactive hyperemia response of thickness the forearm was assessed using a standardized protocol [26 ] ( Figure 1 ). In addition to the previously described apparatus, Common carotid artery (CCA) diastolic diameter (CCAD) was measured by a high-resolution B-mode (7.5 MHz trans-a second pneumatic cuff (arterial occlusion cuff ) was placed on the arm proximal to the venous occlusion cuff and the ducer) echotracking system ( Wall-Track system: W-T, Maastricht, The Netherlands). A complete detailed descrip-gauge. After control flow measurements were obtained, the arterial occlusion cuff was inflated to 300 mm Hg for a tion of this system and the reproducibility of the measurements has been published previously [4, 23] . The accuracy of period of 5 min. The venous occlusion cuff was inflated to 50 mm Hg 10 s before deflating the arterial cuff. At time on a double antibody 'sandwich' technique. Each well of the microtitre plate is coated with a monoclonal antibody specific 'zero' the arterial cuff was deflated and the FBF measured.
for human ET (ET capture antibody). The second antibody FBF was then measured every 15 s until resting flow levels is a monoclonal antibody labelled with an acetyl cholinesterwere reached, and then every minute until a total postase (AChE) and is selective for a different epitope on the ischaemic period of 5 min had elapsed. The following para-ET molecule. The concentration of the analyte is then meters were determined: the flow debt (integral of resting determined by measuring the enzymatic activity of the AChE flow over arterial occlusion time), the post-ischaemic peak with Ellman's reagent. The assay for ET did not cross-react flow (% of baseline), the duration of the hyperaemic phase with big ET. While assay specificity is 100% for ET-1, ET-2 (s), the excess hyperaemic flow (integral of flow and duration and ET-3, the plasma levels reflect principally plasma ET-1 of hyperemic response), and the debt repayment ratio (excess concentrations [27] . The ET detection threshold is 0.1 pg/ml. hyperaemic flow/flow debt). All measurements were made
The inter-and intra-assay coefficients of variation were with a wrist cuff inflated 20 mm Hg above the SBP.
<10%. Routine biochemical parameters were determined by standard methods, and serum albumin and plasma fibrinogen
Laboratory methods
by the nephelometric method.
Arteriovenous fistula blood was obtained immediately before Statistical analysis haemodynamic investigations after an overnight fast. The plasma was separated without delay at 4°C in a refrigerated Data were expressed as means±SD. Student's t-test was centrifuge, and stored at −20°C until plasma ET determina-used for comparison of controls and ESRD patients. tion was performed using an enzyme immunoassy kit Qualitative data were compared using the x2 test. Gender (Cayman Chemicals Company, Ann Arbor, MI, USA) after was used as a dummy variable (1=male, 2=female). an extraction procedure. Briefly, plasma was acidified with Multiple stepwise regression analysis was used to assess the 4% acetic acid, and immunoreactive endothelin was extracted correlations between plasma ET levels and determinants of with a Sep-pac C 18 cartridge ( Waters Associates, Milford, cardiac and arterial parameters and interactions. P<0.05 MA, USA). To determine the recovery rate, a sample was was considered to be significant. spiked with a known amount of ET, then acidified and treated in serial. Each column was pretreated by sequentially
Results
adding methanol, distilled water and 4% acetic acid; the acidified sample was then added. After washing with 25% ethanol, the adsorbed peptide was eluted with 86% ethanol Study population in 4% acetic acid. After elute evaporation, the dry residue Population characteristics are presented in Tables 1-3. was dissolved in assay buffer and subjected to the EIAs. The recovery rate was 60±3%. The immunometric assay is based The two groups were similar regarding age, sex ratio, with decreased flow debt repayment (P<0.001) and lower post-ischaemic peak flow (P<0.01). Post-SBP and DBP. Pulse pressure was increased in ESRD. ischaemic vasodilation was negatively correlated with A total of 21 control subjects (37%) and 42 ESRD age and CCA-IMT (P<0.01). patients (55%) (not significant) had a past history of hypertension, and 15 controls and 22 ESRD patients Blood chemistry and endothelin in ESRD were being treated with antihypertensive drugs ESRD patients had lower total and high density lipo-(stopped 4 weeks before the study). ESRD patients protein (HDL) cholesterol (P<0.05 and P<0.001) had lower body height and weight (P<0.001), and and increased triglycerides (P<0.001) ( Table 3 ). lower body mass index (P<0.001). The ankle/arm Serum albumin was lower in ESRD patients systolic pressure index was similar in the two groups.
(P<0.001), and was negatively correlated with age (P<0.001) and fibrinogen levels (P<0.01). Plasma Cardiovascular parameters fibrinogen was increased in ESRD patients (P<0.001) LV diameter, wall thickness, and mass were increased and was positively correlated with age (r=0.49; in ESRD patients (P<0.001) ( Table 2) . LV outflow P<0.001). velocity integral (LVoVI ), maximum aortic flow velCompared with controls (1.6±1.4; range 0.1-ocity, and stroke index were increased in ESRD 3.7 pg/ml ), plasma ET was increased in ESRD (P<0.001), and inversely correlated with plasma hae-(4.6±3.8; range 0.2-18.7 pg/ml; P<0.001) ( Table 3) , and increased with age (P<0.05). ET concentration was similar in binephrectomized patients and those 
P<0.001
). An age-independent, inverse correlation P<0.001) ( Figure 4 ). In ESRD, CCA-IMT was positively correlated with CF-PWV (r=0.55; P<0.0001). was observed between plasma ET and post-ischaemic flow debt repayment (r=−0.36; P<0.01) and post-After adjustment for age, blood pressure and CCA-IMT, the positive correlation between plasma ET levels ischaemic peak flow (r=−0.49; P<0.001) (Figure 3) .
After adjustment for body surface area, blood pres-and CF-PWV persisted (r=0.23; P<0.05). Plasma ET concentration was not correlated with the dose of sure, haemoglobin level, gender and age, LV mass was positively correlated with plasma ET concentration erythropoietin received by ESRD patients (r=0.137; P=0.227), nor with blood urea, creatinine, blood lipid, ( Table 4) (Figure 4 ). Significant blood pressure-, age-, gender-, and haemoglobin-adjusted positive correlation serum albumin or plasma fibrinogen level abnormalities, nor with smoking habits. was also observed between ET levels and CCA-IMT or intima-media cross-sectional area (r=0.41; Atherosclerotic plaque occurrence was associated Fig. 3 . Correlation between plasma endothelin levels and peak post-ischaemic reactive hyperaemia response in the forearm blood flow in ESRD patients. Decreased post-ischaemic flow debt repayment is associated with increasing plasma endothelin levels. and renal ET gene expression increases with progression of renal insufficiency [28, 29] . This is consistent
with observations in humans that urinary excretion of value r2
ET is increased in chronic renal failure [30] . However, with some exceptions [20, 31, 32] , plasma ET concentra- the kidneys being the only major source of plasma ET in haemodialysis patients and also suggests that decreased renal clearance had limited influence. with plasma ET levels independently from other risk Haemodynamic factors, including shear stress and factors such as plasma fibrinogen levels, smoking habits pulsatile tensile stress [37-42] alter the production and and age ( Table 4) . Lipid abnormalities were not associrelease of ET by endothelial cells in vitro. Increased ated with the presence of atherosclerotic plaques, nor systemic and regional blood flow, and increased pulsatwith decreased post-ischaemic vasodilation or ile pressure are characteristic features observed in increased CCA intima-media thickness.
stable haemodialysis patients [4, [43] [44] [45] [46] , and the present results indicate that these blood flow and pressure alterations are associated with increased plasma levels
Discussion
of ET in ESRD patients. The influence of elevated blood flow on plasma ET concentration in ESRD The present data confirm previous reports that patients patients is consistent with the observation of Wilkie with ESRD have increased plasma ET levels. They et al. [18] , who showed that the ET concentration is extend the previous findings by demonstrating that the significantly higher in haemodialysis patients with elevated plasma ET levels in ESRD patients are signiarteriovenous fistulas than in those dialysed with ficantly correlated with: (i) haemodynamic alterations venous catheters or those treated by peritoneal dialysis. such as increased blood flow and flow velocity and
The correlations between ET concentration and cardiac increased pulse pressure; and (ii) cardiovascular or circulatory function in haemodialysis patients are remodelling, including increased LV mass and opposed to those observed in non-uraemic humans CCA-IMT, and a higher prevalence of atherosclerotic with heart failure. In these patients the ET concentraplaque. These findings are independent of age, gender, tion increases in proportion to left ventricular dysfuncbody size, systemic BP and the usual biochemical tion, being negatively associated with cardiac index abnormalities observed in chronic uraemia. and ejection fraction [11, 12] . These paradoxical findThe elevated plasma ET concentration in ESRD ings illustrate the complexity of mechanisms related to patients may be due to increased production and ET release in vivo. release, decreased metabolic clearance, or both. Renal ET production is increased in experimental uraemia
In ESRD patients the cardiovascular system undergoes significant cardiovascular remodelling char-related to NO release by endothelial cells. They showed that post-ischaemic vasodilation of the radial artery is acterized by an increased left ventricular mass and wall-hypertrophy of major arteries [2] [3] [4] . This cardio-almost abolished in ESRD, blood flow increasing only secondary to increased flow velocity, with no increase vascular remodelling results principally from the combination of chronic volume and pressure overload. in arterial diameter. Since direct vasodilation with nitroprusside induced a similar response in both ESRD Volume overload is principally due to anaemia, arteriovenous shunts and overhydration, while pressure over-patients and controls, authors concluded there was defective NO-mediated function in uraemic patients load is mainly due to increased arterial stiffness and early arterial wave reflections [2, 4, 43, 46 ] . A significant [55] . In ESRD patients an endogenous inhibitor of the L-arginine/nitric oxide pathway accumulates [56, 57] . association between plasma ET concentration and LV mass and CCA-IMT was observed in ESRD patients. Inhibition of NO production could explain increased ET production, since NO inhibits ET production As plasma ET concentration was positively correlated with increased blood flow and flow velocity and [58, 59] .
ET release is stimulated by a variety of vasoactive increased pulsatile load in central arteries the correlation between ET levels and LV mass and CCA IMT hormones, thrombin, inflammatory cytokines, and hypoxia [7, [60] [61] [62] [63] . While increased plasma levels of could be due to common influence of haemodynamic overload both on cardiovascular structures and ET vasoactive substances and cytokines are frequently observed in haemodialysis patients and could activate release. Nevertheless, ET has a mitogenic action, stimulating growth and proliferation in a variety of cells the ET release, the roles of these factors were not analysed in the present study and we therefore could such as smooth muscle cells, endothelial cells, fibroblasts and cardiomyocytes [8] [9] [10] and ET re-only speculate on their possible role. ceptors are present on myocardial cells [47, 48] .
Myocardial ET expression is also induced in response Concluding remarks to pressure and volume overload and both cardiac ET production and myocardial ET receptor density are Overall, the functional importance of circulating ET elevated in chronic heart failure [7, 11, 12, [49] [50] [51] [52] . Thus, remains uncertain. The highest concentration values haemodynamic abnormalities observed in ESRD measured in the present study were in the range of patients could primarily alter the ET release which those inducing vasoconstriction, but in the majority of may in turn directly influence the structure and funcpatients the circulating levels of ET were below the tion of the cardiovascular system. estimated affinity ( K d ) for ET receptors and were Lerman et al. [14] found a significant correlation therefore unlikely to elicit physiological responses [27] . between plasma ET concentrations and the number of ET is predominantly an autocrine/paracrine factor and sites involved by atherosclerotic vascular disease in the majority of ET produced is secreted by the basolatnon-uraemic subjects. The association between atheroeral side of the endothelial cells, and plasma concentrasclerosis and ET was also demonstrated by Jones et al.
tion may not reflect endothelial release, but rather [53] , who found that ET-1 is increased overlying overflow of local production [64, 65] . Therefore, circuatherosclerotic plaques in human arteries. In contrast lating ET could potentially be a marker of local to the observations of Mallamaci et al. (20) , who did production and it is possible that as systemic concentranot find any influence of cardiovascular damage on tions are elevated, local concentrations are even plasma ET levels in chronic renal failure, the present higher [66 ] . study shows that in ESRD patients the prevalence of Finally, the inherent and necessary weakness of the atherosclerotic plaques is correlated with plasma ET present study is its cross-sectional and correlative levels independently from other risk factors such as approach which is not a proof of causal relationship. plasma fibrinogen level, smoking habits or age
The failure to provide interventions with ET antagon-( Table 4 ). The high plasma fibrinogen and lower serum ists does not allow to demonstrate whether the albumin concentrations observed in ESRD patients increased plasma ET levels are the cause or the conwere not correlated with ET levels and may be linked sequence of the observed cardiovascular alterations. to acute phase reaction associated with haemodialysis
Longitudinal clinical studies using receptors antagon- [54] . Activation of ET could occur as a secondary ists could clarify the pathogenic role of ET in cardiophenomenon in atherosclerosis, possibly related to vascular pathology in ESRD patients. atherosclerosis-induced endothelial cell injury.
In conclusion, the present data suggest that elevated Nevertheless, in ESRD an inverse correlation was plasma ET levels in ESRD patients are associated with observed between plasma ET concentrations and postchronic flow-and pulsatile pressure overload. This ischaemic vasodilation in an arterial territory (forearm) increase in plasma ET levels could be one mediator of almost always free of atherosclerotic plaques, sugmechanotransduction contributing to the cardiovasgesting that the increased plasma ET in uraemic cular remodelling observed in chronic uraemia. patients may be related more to generalized endothelial cell dysfunction. Increased plasma ET concentration is
